Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,030
Closed -$300K 2294
2025
Q3
$300K Sell
10,030
-4,952
-33% -$165K 0.02% 1152
2025
Q2
$445K Buy
14,982
+7,399
+98% +$213K 0.04% 656
2025
Q1
$232K Buy
+7,583
New +$255K 0.03% 912
2024
Q4
Sell
-1,072
Closed -$41.6K 1994
2024
Q3
$41.6K Buy
1,072
+1,071
+107,100% +$43.3K ﹤0.01% 1445
2024
Q2
$42 Buy
+1
New +$34 ﹤0.01% 1499
2024
Q1
Sell
-25
Closed -$909 1796
2023
Q4
$909 Buy
+25
New +$819 ﹤0.01% 1030

Other funds holding SRDX

AlphaQuest's SRDX Position: Q4 2025 in Review

AlphaQuest sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 10,030 shares — an estimated $300K sold.

AlphaQuest first reported a position in SRDX in Q4 2023 and held it in 6 quarters. The position peaked at $445K in Q2 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • AlphaQuest reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • AlphaQuest sold 10,030 Surmodics shares in Q4 2025, an estimated $300K.
  • AlphaQuest first reported a position in Surmodics in Q4 2023 and held it in 6 quarters.
  • AlphaQuest's Surmodics position peaked at $445K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on AlphaQuest's 13F filing for Q4 2025, filed 9 Feb 2026.